| |
| |
|
| Insider
Information: |
Hill Stephen A |
| Relationship: |
Director |
| City: |
Woburn |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
31,940 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$15,463 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
31,940 |
|
|
| Total
Value |
$15,463 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 72.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gyre Therapeutics |
GYRE |
Director |
2018-09-06 |
1,190 |
2013-03-08 |
0 |
Premium* |
|
|
Cellectar Bioscienc |
CLRB |
Director |
2020-06-04 |
18,000 |
2014-08-20 |
0 |
Premium* |
|
|
Lipocine Inc |
LPCN |
Director |
2020-12-16 |
12,750 |
2014-11-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LPCN |
Lipocine Inc |
Director |
– • – |
2020-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
12,750 |
0 |
- |
|
| CLRB |
Cellectar Bioscienc |
Director |
– • – |
2020-06-04 |
4 |
B |
$1.08 |
$19,438 |
D/D |
18,000 |
18,000 |
2.39 |
% |
|
| CLRB |
Cellectar Bioscienc |
Director |
– • – |
2018-11-29 |
4 |
S |
$2.21 |
$2,192 |
D/D |
(992) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2018-09-06 |
4 |
D |
$10.07 |
$1,913 |
D/D |
(190) |
1,190 |
0 |
- |
|
| LPCN |
Lipocine Inc |
Director |
– • – |
2017-12-29 |
4 |
AS |
$3.47 |
$4,342 |
D/D |
(1,250) |
5,250 |
0 |
- |
|
| LPCN |
Lipocine Inc |
Director |
– • – |
2017-12-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
6,500 |
0 |
- |
|
| CLRB |
Cellectar Bioscienc |
Director |
– • – |
2016-04-20 |
4 |
B |
$2.12 |
$19,907 |
D/D |
9,390 |
9,920 |
2.39 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2015-12-17 |
4 |
B |
$2.03 |
$10,150 |
D/D |
5,000 |
20,711 |
2.39 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2015-08-28 |
4 |
D |
$6.72 |
$81,621 |
D/D |
(12,146) |
15,711 |
0 |
- |
|
| LPCN |
Lipocine Inc |
Director |
– • – |
2014-11-13 |
4 |
B |
$4.95 |
$19,800 |
D/D |
4,000 |
4,000 |
2.39 |
- |
|
| GYRE |
Gyre Therapeutics |
President & CEO |
• • – |
2014-10-17 |
4 |
A |
$0.00 |
$0 |
D/D |
175,000 |
195,000 |
0 |
- |
|
| CLRB |
Cellectar Bioscienc |
Director |
– • – |
2014-08-20 |
4 |
B |
$3.75 |
$19,875 |
D/D |
5,300 |
5,300 |
2.39 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2013-03-11 |
4 |
B |
$4.38 |
$43,781 |
D/D |
10,000 |
20,000 |
2.81 |
- |
|
| GYRE |
Gyre Therapeutics |
President and CEO |
• • – |
2013-03-08 |
4 |
B |
$4.48 |
$44,796 |
D/D |
10,000 |
10,000 |
2.81 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
